Addus HomeCare’s (ADUS) Outperform Rating Reiterated at Macquarie

Macquarie reiterated their outperform rating on shares of Addus HomeCare (NASDAQ:ADUS) in a research note issued to investors on Friday, Benzinga reports. They currently have a $139.00 price objective on the stock.

ADUS has been the topic of a number of other reports. Royal Bank of Canada reissued an outperform rating and set a $141.00 price objective on shares of Addus HomeCare in a research report on Tuesday, September 3rd. TD Cowen boosted their target price on shares of Addus HomeCare from $128.00 to $137.00 and gave the company a buy rating in a report on Thursday, August 8th. KeyCorp started coverage on shares of Addus HomeCare in a report on Friday. They set an overweight rating and a $150.00 target price on the stock. Stephens restated an overweight rating and set a $138.00 target price on shares of Addus HomeCare in a report on Tuesday, August 6th. Finally, StockNews.com cut shares of Addus HomeCare from a strong-buy rating to a buy rating in a research note on Sunday, July 7th. One research analyst has rated the stock with a sell rating, eight have issued a buy rating and one has issued a strong buy rating to the company. According to data from MarketBeat, the company has an average rating of Moderate Buy and an average target price of $131.38.

Addus HomeCare Stock Performance

ADUS stock opened at $130.63 on Friday. The company has a market capitalization of $2.36 billion, a PE ratio of 32.41, a price-to-earnings-growth ratio of 2.33 and a beta of 1.04. Addus HomeCare has a one year low of $78.35 and a one year high of $136.12. The company’s 50 day moving average price is $129.54 and its two-hundred day moving average price is $117.34.

Addus HomeCare (NASDAQ:ADUS) last posted its quarterly earnings results on Monday, August 5th. The company reported $1.35 EPS for the quarter, topping the consensus estimate of $1.21 by $0.14. The firm had revenue of $286.90 million for the quarter, compared to the consensus estimate of $284.90 million. Addus HomeCare had a net margin of 6.18% and a return on equity of 9.81%. The business’s revenue was up 10.4% compared to the same quarter last year. During the same period last year, the firm posted $0.94 earnings per share. On average, research analysts predict that Addus HomeCare will post 4.58 EPS for the current year.

Insiders Place Their Bets

In other Addus HomeCare news, Director Esteban Lopez sold 500 shares of the business’s stock in a transaction dated Tuesday, September 10th. The stock was sold at an average price of $127.50, for a total value of $63,750.00. Following the completion of the transaction, the director now owns 3,366 shares of the company’s stock, valued at approximately $429,165. The trade was a 0.00 % decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. In related news, EVP Michael D. Wattenbarger sold 21,917 shares of the company’s stock in a transaction on Monday, August 26th. The shares were sold at an average price of $133.29, for a total value of $2,921,316.93. Following the completion of the transaction, the executive vice president now owns 7,215 shares of the company’s stock, valued at approximately $961,687.35. This represents a 0.00 % decrease in their position. The sale was disclosed in a filing with the SEC, which is accessible through this link. Also, Director Esteban Lopez sold 500 shares of the company’s stock in a transaction on Tuesday, September 10th. The stock was sold at an average price of $127.50, for a total transaction of $63,750.00. Following the completion of the transaction, the director now directly owns 3,366 shares of the company’s stock, valued at $429,165. This represents a 0.00 % decrease in their position. The disclosure for this sale can be found here. In the last 90 days, insiders sold 22,917 shares of company stock valued at $3,050,082. 4.60% of the stock is owned by insiders.

Institutional Trading of Addus HomeCare

Several hedge funds have recently bought and sold shares of ADUS. Virtu Financial LLC purchased a new stake in Addus HomeCare in the 4th quarter worth $322,000. Wellington Management Group LLP raised its position in shares of Addus HomeCare by 1.2% during the 4th quarter. Wellington Management Group LLP now owns 798,435 shares of the company’s stock valued at $74,135,000 after buying an additional 9,548 shares in the last quarter. Vanguard Group Inc. raised its position in shares of Addus HomeCare by 3.2% during the 4th quarter. Vanguard Group Inc. now owns 1,257,440 shares of the company’s stock valued at $116,753,000 after buying an additional 38,876 shares in the last quarter. GAMMA Investing LLC raised its position in shares of Addus HomeCare by 40.8% during the 1st quarter. GAMMA Investing LLC now owns 556 shares of the company’s stock valued at $57,000 after buying an additional 161 shares in the last quarter. Finally, Bridge City Capital LLC raised its position in shares of Addus HomeCare by 46.4% during the 1st quarter. Bridge City Capital LLC now owns 30,999 shares of the company’s stock valued at $3,203,000 after buying an additional 9,819 shares in the last quarter. Hedge funds and other institutional investors own 95.35% of the company’s stock.

About Addus HomeCare

Addus HomeCare Corporation, together with its subsidiaries, provides personal care services to elderly, chronically ill, disabled persons, and individuals who are at risk of hospitalization or institutionalization in the United States. The company operates through three segments: Personal Care, Hospice, and Home Health.